European Journal of Cancer
Volume 41, Issue 4 , Pages 502-507, March 2005

Shifting paradigms in prostate cancer; docetaxel plus low-dose prednisone – finally an effective chemotherapy

Rotterdam Cancer Institute, Erasmus University Medical Center, Department of Medical Oncology, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands

Received 6 December 2004; accepted 7 December 2004.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(04)00994-3

doi:10.1016/j.ejca.2004.12.007

European Journal of Cancer
Volume 41, Issue 4 , Pages 502-507, March 2005

Article Tools